Navigation Links
Noncoding RNAs offer huge therapeutic and diagnostic potential
Date:2/14/2013

microRNAs might play in disease is also examined in "The Mix of Two Worlds: Non-Coding RNAs and Hormones." Marc Weinberg and Kevin Morris, The Scripps Research Institute, La Jolla, CA, describe current understanding of the regulatory function of long noncoding RNAs and how it might be used to create an entirely new area of pharmacology in "Long Non-Coding RNA Targeting and Transcriptional De-Repression."

"The astoundingly diverse roles of noncoding RNAs across many areas of biology and disease are among the most exciting areas of current research," says Executive Editor Fintan Steele, PhD, SomaLogic, Inc., Boulder, CO. "It is increasingly clear that as our knowledge of these molecules improves, so will potential therapeutic applications that take advantage of their unique biological properties."


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100 x2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Long noncoding RNAs control development of fat cells
2. IU biologists offer clearer picture of how protein machine systems tweak gene expression
3. LABS, Inc. Launches Suite of Next-Generation Test Offerings; Focuses on Expanding Complex Biologic Testing Portfolio in 2012
4. Discovery offers insight into treating viral stomach flu
5. Genetic abnormality offers diagnostic hope for childrens cancer
6. M2SYS Technology Partners with Hitachi to Offer Innovative Biometric Finger Vein Scanner to US Market
7. Chimpanzee ground nests offer new insight into our ancestors descent from the trees
8. Early detection techniques offer hope for improved outcomes in lung cancer patients
9. University of Minnesota startup offers game-changing energy solutions that reduce CO2 emissions
10. NCEAS researchers offer new ecological model for deep-water oil spills
11. Battle of the sexes offers evolutionary insights
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Noncoding RNAs offer huge therapeutic and diagnostic potential
(Date:2/5/2015)... Carolina , 5. Februar 2015 /PRNewswire/ ... als spezialisiertes Logistikunternehmen und hat eine neue ... klinische Logistikfirma (Clinical Logistics Organization – CLO) ... neuen Kampagne lautet First , mit ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... ( http://www.nxt-id.com/ ) as part of its 2015 marketing ... Company launched its new consumer website for Wocketwallet.com earlier ... CEO of NXT-ID said, "Our new corporate website naturally ...
(Date:2/5/2015)... 28, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... Global Online CEO Conference on January 29 th ... Pereira , CEO of NXT-ID will present and host ... Wocket smart wallet and its full suite of biometric ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
... was lost in the shadows of cancer research for decades ... Mina Bissell, Distinguished Scientist with Berkeley Lab,s Life Sciences Division ... aerobic glycolysis - glucose metabolism in the presence of oxygen ... malignant cells but is itself a cancerous event. "A ...
... and said about "platinum" open access as a step beyond ... has been seen of its practical implementation. On 1 January ... Deutsche Entomologische Zeitschrift and Zoosystematics and Evolution ... joining the journal publishing platform of Pensoft Publishers and adopting ...
... Halomonas are a hardy breed of bacteria. ... and pressures that would kill most other organisms. These traits ... sandstone formations that also happen to be useful for hydrocarbon ... The analysis , the first unobstructed view of ...
Cached Biology News:Role for sugar uptake in breast cancer revealed 2Role for sugar uptake in breast cancer revealed 32 of the oldest German journals in Zoology go for 'platinum' open access 2Oil- and metal-munching microbes dominate deep sandstone formations 2
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital IQ ... Stock Report coverage on MabVax Therapeutics Holdings Inc . ... a clinical stage biotechnology company focused on the development ... needs in the treatment of cancer. MabVax has discovered ... the protective immune responses generated by patients who have ...
(Date:2/26/2015)... N.J. , Feb. 26, 2015 On ... and its affiliated companies, Wilentz, Goldman & Spitzer, ... trade secrets lawsuit against Genewiz Inc. in excess of ... and utilized GenScript,s trade secrets, and that it improperly ... entered an order denying motions for judgment notwithstanding the ...
(Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading ... Kate Black as Privacy Officer and Corporate Counsel. ... state privacy laws as well as health care regulations. ... she will be responsible for reviewing, updating and enhancing ... the U.S. and abroad. She joined the company January ...
(Date:2/26/2015)... /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... develops and commercializes proprietary technologies and products for advanced ... for the fiscal first quarter ended December  31, 2014. ... dollars (CAD), unless otherwise stated. "During ... from our existing customers and add to our sales ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 323andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6
... Germany and MILAN, October 18, 2011 ... at EuroSpine Milan for the first time, opening up ... For the first time joimax® presents the ... the novel pain therapy product "Multiuse". The new Multiuse-Set ...
... TARRYTOWN, N.Y., Oct. 17, 2011 Regeneron Pharmaceuticals, Inc. ... it intends to offer, subject to market and other ... notes due 2016 in a private placement.  The notes ... qualified institutional buyers pursuant to Rule 144A under the ...
... Cellular Dynamics International (CDI) today announced that it ... Wall Street Journal Technology Innovation Awards. ... are determined by a panel of independent judges who evaluated ... the award in 16 categories.  Of these, the panel chose ...
Cached Biology Technology:joimax® Launches Numerous Innovations at EuroSpine Milan From 19 To 21 October 2011 2Regeneron Pharmaceuticals Announces Proposed Offering of Convertible Senior Notes due 2016 2Regeneron Pharmaceuticals Announces Proposed Offering of Convertible Senior Notes due 2016 3Regeneron Pharmaceuticals Announces Proposed Offering of Convertible Senior Notes due 2016 4Regeneron Pharmaceuticals Announces Proposed Offering of Convertible Senior Notes due 2016 5Cellular Dynamics International's (CDI) Human Induced Pluripotent Stem Cell (iPSC) Technology Named the Gold Winner in The Wall Street Journal 2011 Technology Innovation Awards 2
Request Info...
Mouse monoclonal [DJR3] to DcR1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
...
Rabbit polyclonal to Quinolinic acid ( Abpromise for all tested applications). Antigen: Synthetic quinolinic acid conjugated to bovine serum albumin....
Biology Products: